Literature DB >> 19258935

Ethnic disparities in cervical cancer survival among Medicare eligible women in a multiethnic population.

Ann L Coker1, Katherine S Eggleston, Xianglin L Du, Lois Ramondetta.   

Abstract

UNLABELLED: To determine predictors of cervical cancer survival by socioeconomic status (SES), urbanization, race/ethnicity, comorbid conditions, and treatment among elderly Medicare-eligible women whose conditions were diagnosed with cervical cancer in a multiethnic population.
METHODS: : A total of 538 women with cervical cancer aged 65 years or older were identified from 1999 to 2001 from the Texas Cancer Registry and were linked with the state Medicare data and Texas Vital Records to determine survival times. All women had similar access to care through Medicare fee-for-services insurance. A composite measure of SES was created using census tract-level data as was urbanization. Treatment and comorbid conditions were available from the Medicare data. Cox proportional hazards modeling was used for all-cause and cervical cancer-specific survival analysis.
RESULTS: : Increased age (P < 0.0001) and advanced tumor stage (P < 0.0001) were associated with poorer all-cause and cervical cancer-specific survival. Having a comorbid condition was associated with all-cause survival (P < 0.01) but not cervical cancer-specific mortality. After adjusting for confounders, women receiving some form of treatment were almost half as likely to die with cervical cancer (adjusted hazard ratio = 0.68; 95% confidence interval, 0.52-0.89). After adjustment for all confounders, Hispanic women consistently had lower all-cause and cervical cancer-specific mortality rates relative to non-Hispanic white and non-Hispanic black women.
CONCLUSIONS: : Among women with similar health care coverage, Hispanic women had consistently lower all-cause and cervical cancer-specific mortality rates than other older women whose conditions were diagnosed with this disease in Texas. The presence of comorbid conditions and treatment were important predictors of survival, yet these factors do not explain the survival advantage for Hispanic women.

Entities:  

Mesh:

Year:  2009        PMID: 19258935     DOI: 10.1111/IGC.0b013e318197f343

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  14 in total

1.  Racial/ethnic disparities in survival among men diagnosed with prostate cancer in Texas.

Authors:  Arica White; Ann L Coker; Xianglin L Du; Katherine S Eggleston; Melanie Williams
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

2.  MTHFR C677T and A1298C polymorphisms and cervical carcinoma susceptibility: meta-analyses based on 4,421 individuals.

Authors:  Wen-Lei Zhuo; Liang Zhang; Jun-Jun Ling; Yi Zhu; Zheng-Tang Chen
Journal:  Mol Biol Rep       Date:  2012-06-19       Impact factor: 2.316

3.  Association of census tract-level socioeconomic status with disparities in prostate cancer-specific survival.

Authors:  Vincent L Freeman; Ana C Ricardo; Richard T Campbell; Richard E Barrett; Richard B Warnecke
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-07-22       Impact factor: 4.254

4.  Avoidable tragedies: Disparities in healthcare access among medically underserved women diagnosed with cervical cancer.

Authors:  Lois M Ramondetta; Larissa A Meyer; Kathleen M Schmeler; Maria E Daheri; Jessica Gallegos; Michael Scheurer; Jane R Montealegre; Andrea Milbourne; Matthew L Anderson; Charlotte C Sun
Journal:  Gynecol Oncol       Date:  2015-10-21       Impact factor: 5.482

5.  Disparities in cervical cancer survival among Asian-American women.

Authors:  Van T Nghiem; Kalatu R Davies; Wenyaw Chan; Zuber D Mulla; Scott B Cantor
Journal:  Ann Epidemiol       Date:  2015-10-19       Impact factor: 3.797

6.  Racial disparities in cervical cancer mortality in an African American and European American cohort in South Carolina.

Authors:  Swann Arp Adams; Alexandria Fleming; Heather M Brandt; Deborah Hurley; Susan Bolick-Aldrich; Sharon M Bond; James R Hebert
Journal:  J S C Med Assoc       Date:  2009-12

7.  Does comorbidity explain the ethnic inequalities in cervical cancer survival in New Zealand? A retrospective cohort study.

Authors:  Naomi Brewer; Barry Borman; Diana Sarfati; Mona Jeffreys; Steven T Fleming; Soo Cheng; Neil Pearce
Journal:  BMC Cancer       Date:  2011-04-12       Impact factor: 4.430

8.  Impact of age on morbidity and outcome of concurrent radiochemotherapy in high-risk FIGO stage I to IVA carcinoma of the uterine cervix following laparoscopic surgery.

Authors:  Thea Laurentius; Annelore Altendorf-Hofmann; Oumar Camara; Ingo B Runnebaum; Thomas G Wendt
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-15       Impact factor: 4.553

9.  A retrospective cohort study of patients with stomach and liver cancers: the impact of comorbidity and ethnicity on cancer care and outcomes.

Authors:  Diana Sarfati; Jason Gurney; James Stanley; Jonathan Koea
Journal:  BMC Cancer       Date:  2014-11-07       Impact factor: 4.430

10.  An examination of racial differences in 5-year survival of cervical cancer among African American and white American women in the southeastern US from 1985 to 2010.

Authors:  Janaka Weragoda; Andres Azuero; Suguna Badiga; Walter C Bell; Roland Matthews; Chandrika Piyathilake
Journal:  Cancer Med       Date:  2016-05-17       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.